Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.
A homogeneous substrate-labeled fluorescent immunoassay was developed for the measurement of kanamycin concentrations in serum. A fluorogenic drug reagent (FDR) (beta-galactosyl-umbelliferone-tobramycin) was prepared that is nonfluorescent under the conditions of the assay but is hydrolyzed upon cat...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1986
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180483/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3524437/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.6.961 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|